News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ozgene Pty Ltd Reached Milestone For Organon



10/19/2005 5:13:05 PM

PERTH, Australia, March 21 /PRNewswire/ -- Ozgene Pty Ltd (Perth, Australia) announced this week that it has reached a final milestone in one it's drug target validation projects for NV Organon (The Netherlands).

This milestone marks the successful completion of the first project out of a series of studies undertaken between Ozgene and Organon.

The contact research undertaken by Ozgene will form the basis for further studies by the Dutch pharmaceutical company.

"We are very excited to deliver these results to Organon and are looking forward to the continuing collaboration between Ozgene and Organon" commented Dr Frank Koentgen (Director and CEO of Ozgene).

"We are happy with the progress achieved and look forward to the results of our cooperation with Ozgene" said Ton Rijnders, VP Research, N.V. Organon.

Business Development Office email: ozgene@ozgene.com tel: +61-8-9212-2200

Ozgene Pty Ltd

CONTACT: Business Development Office, email: ozgene@ozgene.com, tel:+61-8-9212-2200


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES